World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
98
Citations
77727
World Ranking
767
National Ranking
436

Medicine

D-Index
98
Citations
77731
World Ranking
8720
National Ranking
4495

Richard S. Hotchkiss publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Richard S. Hotchkiss sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 351 publications — 74th percentile

74% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Richard S. Hotchkiss D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Richard S. Hotchkiss sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 98 D-Index — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Richard S. Hotchkiss is affiliated with Washington University in St. Louis in the United States. Their research primarily focuses on medical and immunological sciences, particularly addressing critical issues related to infectious diseases and immune responses.

The scientist's recent publications span several vital topics in the area of sepsis and COVID-19, reflecting research interests in immune dysregulation and inflammatory processes. Notable papers include:

  • Severe immunosuppression and not a cytokine storm characterizes COVID-19 infections, 2020, published in JCI Insight
  • Distinct inflammatory profiles distinguish COVID-19 from influenza with limited contributions from cytokine storm, 2020, Science Advances
  • Immunotherapies for COVID-19: lessons learned from sepsis, 2020, The Lancet Respiratory Medicine
  • Reframing sepsis immunobiology for translation: towards informative subtyping and targeted immunomodulatory therapies, 2024, The Lancet Respiratory Medicine
  • COVID-19 disease and immune dysregulation, 2022, Best Practice & Research Clinical Haematology

Frequent coauthors collaborating with Richard S. Hotchkiss include Kenneth E. Remy, Monty B. Mazer, Lyle L. Moldawer, Scott C. Brakenridge, and Charles C. Caldwell. This network reflects a collaborative approach toward better understanding sepsis, immune responses, and COVID-19-related pathologies.

The main fields of study for the scientist are Medicine and Immunology and Microbiology. Subfields of significant publication output include infectious diseases, epidemiology, immunology, neurology, and critical care and intensive care medicine.

The research topics covered show a focus on clinical and immunological aspects, notably:

  • Sepsis Diagnosis and Treatment
  • COVID-19 Clinical Research Studies
  • Immune Response and Inflammation
  • SARS-CoV-2 and COVID-19 Research
  • Long-Term Effects of COVID-19
  • Adrenal Hormones and Disorders
  • Inflammation biomarkers and pathways

Richard S. Hotchkiss regularly publishes in venues such as Shock, JCI Insight, bioRxiv (Cold Spring Harbor Laboratory), Critical Care Explorations, and The Lancet Respiratory Medicine.

Best Publications

  • The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)

    Mervyn Singer;Clifford S. Deutschman;Christopher Warren Seymour;Manu Shankar-Hari

  • The pathophysiology and treatment of sepsis.

    Richard S Hotchkiss;Irene E Karl

  • Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy

    Richard S. Hotchkiss;Guillaume Monneret;Didier Payen

  • Immunosuppression in Patients Who Die of Sepsis and Multiple Organ Failure

    Jonathan S. Boomer;Kathleen To;Kathy C. Chang;Osamu Takasu

  • Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach

    Richard S Hotchkiss;Guillaume Monneret;Didier Payen

  • Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction

    Hotchkiss Rs;Swanson Pe;Freeman Bd;Tinsley Kw

  • Sepsis and septic shock

    Richard R.S. Hotchkiss;Lyle Linc Moldawer;Steven Opal;Konrad Reinhart

  • MECHANISMS OF DISEASE Cell Death

    Richard S. Hotchkiss;Andreas Strasser;Jonathan E. McDunn;Paul E. Swanson

  • Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans.

    Hotchkiss Rs;Tinsley Kw;Swanson Pe;Schmieg Re

  • Apoptosis and caspases regulate death and inflammation in sepsis

    Richard S. Hotchkiss;Donald W. Nicholson

  • Host-directed therapies for bacterial and viral infections

    Stefan H. E. Kaufmann;Anca Dorhoi;Richard S. Hotchkiss;Ralf Bartenschlager

  • A guiding map for inflammation

    Mihai G Netea;Frances Balkwill;Michel Chonchol;Fabio Cominelli

  • Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte.

    R. S. Hotchkiss;K. C. Chang;P. E. Swanson;K. W. Tinsley

  • The sepsis seesaw: tilting toward immunosuppression.

    Richard S Hotchkiss;Craig M Coopersmith;Jonathan E McDunn;Thomas A Ferguson

  • Prevention of lymphocyte cell death in sepsis improves survival in mice.

    R. S. Hotchkiss;K. W. Tinsley;P. E. Swanson;K. C. Chang

  • Mechanisms of Cardiac and Renal Dysfunction in Patients Dying of Sepsis

    Osamu Takasu;Joseph P. Gaut;Eizo Watanabe;Kathleen To

  • Depletion of Dendritic Cells, But Not Macrophages, in Patients with Sepsis

    Richard S. Hotchkiss;Kevin W. Tinsley;Paul E. Swanson;Mitchell H. Grayson

  • Reevaluation of the role of cellular hypoxia and bioenergetic failure in sepsis.

    Richard S. Hotchkiss;Irene E. Karl

  • Differential modulation of endotoxin responsiveness by human caspase-12 polymorphisms

    Maya Saleh;John P. Vaillancourt;Rona K. Graham;Matthew Huyck

  • Persistent lymphopenia after diagnosis of sepsis predicts mortality.

    Anne M. Drewry;Navdeep Samra;Lee P. Skrupky;Brian M. Fuller

  • Overexpression of Bcl-2 in Transgenic Mice Decreases Apoptosis and Improves Survival in Sepsis

    Hotchkiss Rs;Swanson Pe;Knudson Cm;Chang Kc

Frequent Co-Authors

Paul E. Swanson
Paul E. Swanson University of Washington
W. Michael Dunne
W. Michael Dunne bioMérieux (France)
Robert H. Mach
Robert H. Mach University of Pennsylvania
Charles C. Caldwell
Charles C. Caldwell University of Cincinnati
Lyle L. Moldawer
Lyle L. Moldawer University of Florida
William G. Hawkins
William G. Hawkins Washington University in St. Louis
Joseph J. H. Ackerman
Joseph J. H. Ackerman Washington University in St. Louis
Thomas A. Ferguson
Thomas A. Ferguson Washington University in St. Louis
Marin H. Kollef
Marin H. Kollef Washington University in St. Louis
William C. Chapman
William C. Chapman Washington University in St. Louis

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in advancing their knowledge in Immunology, exploring related online degrees can open up diverse career pathways in healthcare and research. Many nursing professionals choose to specialize further by pursuing a Nurse Practitioner (NP) program. If you're considering this route, it’s helpful to know which programs are more accessible; for instance, this guide on what is the easiest np program can provide valuable insights.

Psychiatric Mental Health Nurse Practitioner (PMHNP) programs are another popular option, especially for those aiming to address mental health issues related to immunological conditions. Finding quality education with strong clinical opportunities is key. Check out this list of the top pmhnp programs known for excellent clinical placement rates.

For students mindful of tuition costs, affordable options do exist. This resource on the cheapest online pmhnp certificate programs highlights budget-friendly paths to certification without compromising quality.

Finally, understanding the financial outlook is crucial. Advanced degrees like a Doctor of Nursing Practice (DNP) significantly impact earning potential. Explore the dnp salary by specialty to see how different specializations, including immunology-related fields, compare across the U.S.

Best Scientists Citing Richard S. Hotchkiss

Trending Scientists

Recently Published Articles